Q155131 (Q155131): Difference between revisions
Created a new Item |
Changed an Item |
||
| Property / VIAF ID | |||
| Property / VIAF ID: 18263784 / rank | |||
Normal rank | |||
| Property / VIAF ID: 18263784 / qualifier | |||
identifier acquisition method: nlg-matchmaker | |||
| Property / ISNI | |||
| Property / ISNI: 0000000063215069 / rank | |||
Normal rank | |||
| Property / ISNI: 0000000063215069 / qualifier | |||
identifier acquisition method: nlg-matchmaker | |||
Latest revision as of 09:50, 23 November 2025
No description defined
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
No description defined |
Statements
Pangborn
0 references
Mary C.
0 references
Τεκμήριο: Cardiolipin antigens, preparation and chemical and serological control, 1951:
PDF, σ.τ. (Mary C. Pangborn, Ph.D.· Division of Laboratories and Research, New York State Department of Health, Albany, N.Y.)
0 references
LC/NACO (αρχείο καθιερωμένων επικεφαλίδων), ημ/νία προσπέλασης 8 Μαΐου 2021
(επικεφαλίδα: Pangborn, Mary C.)
0 references